Clinical Trial Update: A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TEV-56286 for multiple system atrophy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• TEV-56286

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Multiple System Atrophy | Phase 2 | Status: RECRUITING